SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-030275
Filing Date
2022-08-18
Accepted
2022-08-18 16:58:22
Documents
13
Period of Report
2022-08-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20004078x23_8k.htm   iXBRL 8-K 51571
2 EXHIBIT 99.1 ny20004078x23_ex99-1.htm EX-99.1 17049
  Complete submission text file 0001140361-22-030275.txt   212737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220817.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220817_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220817_pre.xml EX-101.PRE 16040
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20004078x23_8k_htm.xml XML 4051
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221178032
SIC: 2835 In Vitro & In Vivo Diagnostic Substances